Results 1 to 2 of 2 matches
Category 6 - PATHOLOGY SERVICES
Category 6 - PATHOLOGY SERVICES
73336 - Additional Information
Item Start Date:
01-Dec-2013
Description Updated:
01-Apr-2020
Schedule Fee Updated:
01-Dec-2013
Group
P7 - Genetics
A test of tumour tissue from a patient with stage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib, vemurafenib or encorafenib under the Pharmaceutical Benefits Scheme are fulfilled.
Fee: $230.95 Benefit: 75% = $173.25 85% = $196.35
Results 1 to 2 of 2 matches
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change